Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemotherapy_protocol
|
| gptkbp:clinicalTrialPhase |
gptkb:EORTC-NCIC_trial
|
| gptkbp:duration |
6 cycles of adjuvant temozolomide
|
| gptkbp:improves |
overall survival in glioblastoma patients
|
| gptkbp:includes |
gptkb:temozolomide
radiotherapy |
| gptkbp:introducedIn |
2005
|
| gptkbp:namedAfter |
gptkb:Roger_Stupp
|
| gptkbp:publishedIn |
gptkb:New_England_Journal_of_Medicine
|
| gptkbp:radiotherapyDosage |
60 Gy in 30 fractions
|
| gptkbp:standardOfCareFor |
newly diagnosed glioblastoma
|
| gptkbp:temozolomideDosage |
75 mg/m2 daily during radiotherapy
150–200 mg/m2 for 5 days every 28 days after radiotherapy |
| gptkbp:usedFor |
glioblastoma treatment
|
| gptkbp:bfsParent |
gptkb:glioblastoma
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Stupp protocol
|